Investigating how B cells respond to Merkel cell carcinoma
Understanding B cell immunity in Merkel cell carcinoma
This study is looking at how certain immune cells called B cells can help fight Merkel cell carcinoma, a rare skin cancer, especially in patients with advanced stages of the disease who are receiving immunotherapy, to find ways to improve treatment results.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10890976 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of B cells in the immune response to Merkel cell carcinoma (MCC), a rare and aggressive skin cancer. The study aims to explore how B cells can recognize and attack MCC cells, particularly in patients who have advanced disease and respond to immunotherapy. By analyzing the immune system's function, especially the activity of B cells and their interactions with other immune cells, the research seeks to uncover mechanisms that could enhance treatment outcomes for patients with MCC.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with Merkel cell carcinoma, particularly those with advanced or metastatic disease.
Not a fit: Patients with non-cancerous conditions or those with early-stage MCC may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved immunotherapy strategies for patients with Merkel cell carcinoma.
How similar studies have performed: Previous studies have shown promising results in understanding immune responses in similar cancers, suggesting potential for success in this research.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Schnabel, Julia — Harvard Medical School
- Study coordinator: Schnabel, Julia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.